<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> often display startling intratumor <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in various features including histology, gene expression, genotype, and metastatic and proliferative potential </plain></SENT>
<SENT sid="1" pm="."><plain>This phenotypic and <z:hpo ids='HP_0001425'>genetic heterogeneity</z:hpo> plays an important role in <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e>, and therapeutic resistance </plain></SENT>
<SENT sid="2" pm="."><plain>In this issue of the journal (beginning on page 1388), Merlo et al. report their use of molecular data from 239 patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> to evaluate the propensity of major diversity indices for predicting progression to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>This work helps elucidate the implications of molecular <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> for the evolution of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
</text></document>